title: Ethical considerations in clinical cardiac xenografting.
authors.forename: R N
authors.initials: RN
authors.lastname: Pierson
authors.forename: D J
authors.initials: DJ
authors.lastname: White
authors.forename: J
authors.initials: J
authors.lastname: Wallwork
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology; D015703:Antigens, CD / Q000502:physiology; D018958:CD55 Antigens; D003169:Complement Inactivator Proteins / Q000502:physiology; D003165:Complement System Proteins / Q000502:physiology; D004992:Ethics, Medical; D006084:Graft Rejection / Q000209:etiology / Q000276:immunology; D006085:Graft Survival / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000502:physiology; D014183:Transplantation, Heterologous; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D015703:Antigens, CD; C497857:CD46 protein, human; D018958:CD55 Antigens; D003169:Complement Inactivator Proteins; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D003165:Complement System Proteins